Eric Lefkofsky is one of the biggest names in medical philanthropy throughout the United States. Having donated tens of millions of dollars to cancer research alone, the entrepreneur has become one of the most appreciated philanthropists of his age. But unlike many independently wealthy philanthropists, Lefkofsky likes to take a more hands-on approach to his largesse. In 2016, Lefkofsky founded a company, Tempus, which seeks to revolutionize the way in which cancer is treated through putting the most powerful information available into the hands of oncologists.
After a close family member was diagnosed with cancer, Lefkofsky was dismayed to discover that many oncologists working in the field today have less access to vital information than the typical truck driver. This disturbing realization prompted Lefkofsky to begin looking into ways in which better sources of data and analytic intelligence can be put into the hands of treating physicians in real-time. He eventually came to the conclusion that such new technologies as CRISPR and human gene sequencing were not being used to anywhere near their full potential. These new technologies were a potential treasure trove of data that could be used by oncologists in real time to formulate far more effective treatment protocols for each of their patients and learn more about Eric.
Eventually, the idea for Tempus began coalescing in Lefkofsky’s head. It would be a means to effectively allow oncologists to answer the same questions, even with complex data sets, that would have previously only been possible to effectively answer through the use of large-scale clinical studies. Even a decade ago, such a platform would have been impossible to create. But today, through the use of such means as artificial intelligence and the vast computing power contained in the cloud, it is possible to sift through mind-boggling volumes of data, teasing out the subtle patterns and correlations that exist between seemingly unrelated factors and more information click here.
Lefkofsky believes that this new technology will effectively enable physicians to gain a near-infinite granularity in their understanding of how patients react to medicines and treatments. It will eventually allow doctors to custom design treatment protocols to each individual patient.
More Visit: https://www.bizjournals.com/chicago/news/2017/04/12/groupon-co-founder-moves-to-help-youth-access-art.html
Transparency and quality medical care are two priorities for InnovaCare Health. Dr. Rick Shinto, along with three other medical professionals are working to build InnovaCare Health’s teamwork to build success. He is credited as being the reason why InnovaCare Health enjoys the success it does today. Shinto is known for inspiring people to give it their all and his leadership wisdom and experience in the medical field help him make InnovaCare successful.
InnovaCare makes the average trip to the doctor’s office more affordable for the average person. Now more people than ever in Puerto Rico are getting health insurance. 70 percent choose InnovaCare because of its affordability and high quality care. Read more about Innovacare at Crunchbase.
Shinto and his team of medical professionals are dedicated to making it easier for average working citizens to get the healthcare they need and their goodwill and high ethical standards let them have high success rates.
InnovaCare Health has two medical affiliates: MMM Healthcare Inc. and PMC Medicare Choice Inc. PMC and MMC are both dedicated to providing high quality health and medical care in Puerto Rico. Both affiliates promote physical and psychological wellbeing of their patients. They have both demonstrated customer protection and improvement of quality and have received NQA accreditation.
Shinto brings years of leadership and technical experience to InnovaCare Health and he was awarded the Ernst & Young Entrepreneurship of the Year award when he was president of Aveta Inc, which he was before joining InnovaCare. Dr. Rick Shinto began his career as an intern in Southern California. He served as vice president to medical management before becoming Chief Medical Officer at CalOptima’s Health Plan. He was also Chief Medical and Operating Officer at Medical Pathways Management Company. Follow Innovacare at LinkedIn.
Dr. Shinto has also written several works on clinical management. He received his M.B.A. at the University of Redlands after receiving his medical degree from New York State University. His extensive medical and business background is what helps him guide InnovaCare to a future of even more success while also helping average people afford medical care. He is the definition of ethical business leadership and will continue to do many great things in the future.